Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Bitcoin bottom likely in, upside ahead: Bernstein
-
Bernstein SocGen Group Starts NTPC Green Energy (NTPCGREE:IN) at Underperform
-
Bernstein SocGen Group Starts Tata Power (TPWR:IN) at Outperform
-
Bernstein SocGen Group Starts JSW Energy Ltd (JSW:IN) at Outperform
-
Bernstein SocGen Group Starts Adani Power Limited (ADANI:IN) at Outperform
-
Bernstein Reiterates Market Perform Rating on Southwest (LUV)
-
Bernstein on Gilead Sciences (GILD) Amid Ouro Acquisition
-
Bernstein: 'Bitcoin Looks Bottomed, Strategy (MSTR) Remains Resilient'
-
Bernstein Reiterates Underperform Rating on CoreWeave (CRWV)
-
McCormick & Company (MKC) PT Lowered at Bernstein Amid Potential Reverse Morris Trust Deal
-
Minimus Launches Open Source Program, Bringing Hardened Images to Critical Infrastructure Projects
-
SK Hynix to buy $8 billion in ASML chipmaking tools in largest disclosed order
-
This crypto stocks is the best proxy for stablecoin upside
-
This U.S. natural gas stock is a new Top Pick at Bernstein
-
Motor racing-F1 owner Liberty Media can ride out Mideast conflict
-
Bernstein: 'Own Both NVDA and AVGO'
-
Bernstein Thoughts on Super Micro Computer (SMCI) Amid Smuggling Charges
-
Bernstein Reorders Americas Oil & Gas Stock Rankings and Highlights Top Ideas
-
Kosmos Energy (KOS:LN) (KOS) PT Raised to GBP0.83 at Bernstein SocGen Group
-
Bernstein Shares Highlights from the Ermenegildo Zegna Group (ZGN) FY25 Conference Call
-
XPeng (XPEV) PT Raised to $22 at Bernstein As 'Q4 Delivers First Profit'
-
DELL, HPQ, or HPE: Which IT hardware stock to buy in 2026
-
Form 4 Maze Therapeutics, Inc. For: Mar 20 Filed by: Bernstein Harold
-
Bernstein SocGen Group Starts Immunovant (IMVT) at Market Perform
-
Bernstein SocGen Group Starts Roivant Sciences (ROIV) at Outperform
-
FedEx (FDX) PT Raised to $466 at Bernstein SocGen Group
-
Bernstein SocGen: 'unique opportunity for Apple to gain share in both smartphones and PCs'
-
Bernstein on SMCI (SMCI): 'Do we need to add a smuggling line to our SMCI revenue build?'
-
These are the best EU pharma stocks to buy: analyst
-
Unilever in talks to sell food business to smaller US rival McCormick
-
Bernstein SocGen Group Downgrades China Gas Holdings Ltd. (384:HK) (CGHLY) to Underperform
-
Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease
-
Bernstein on Micron Technology (MU): 'We Turn More Constructive'
-
Kanzhun Ltd. (BZ) PT Lowered to $16.50 at Bernstein SocGen Group
-
General Mills (GIS) PT Lowered to $44 at Bernstein Following Guide Cut
-
Five Below (FIVE) PT Raised to $233 at Bernstein
-
Bernstein: 'Waste Management (WM) is well positioned for an inflection in FCF'
-
Bernstein: 'Howmet Aerospace Inc. (HWM) a Uniquely Attractive Business'
-
Bernstein SocGen Group Starts Novo Nordisk (NOVOB:DC) (NVO) at Underperform
-
Valor PayTech Strengthens Executive Team With Key Leadership Appointments
-
Bernstein on Global Memory: 'Price increase more than expected in 2QCY26'
-
Bernstein on U.S. Machinery: '2026 manufacturing capital budgets signal start of the next wave'
-
Bernstein Reiterates Market Perform Rating on Titan America (TTAM)
-
Bernstein: 'We View SAP AG (SAP) As the Best-positioned Beneficiary'
-
Bernstein on NVIDIA (NVDA) Following Financial Analyst Q&A at GTC
-
Lululemon Athletica Inc. (LULU) PT Lowered to $180 at Bernstein
-
Bernstein: 'A unique opportunity for Apple (AAPL) to gain share in both smartphones and PCs'
-
Form 4 BEL FUSE INC /NJ For: Mar 15 Filed by: BERNSTEIN DANIEL
-
Bernstein: 'CoreWeave (CRWV) is Meaningfully Overvalued Today'
-
Bernstein on NVIDIA (NVDA) Following Keynote: 'We Liked What We Heard'

